AIM
AVEO

Assured Investment Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Assured Investment Management’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-28,081
Closed -$230K – 1072
2019
Q1 		$230K Buy
+28,081
New +$290K ﹤0.01% 774
2018
Q4 		– Sell
-1,615
Closed -$53K – 1405
2018
Q3 		$53K Sell
1,615
-24,239
-94% -$623K ﹤0.01% 1088
2018
Q2 		$584K Buy
25,854
+1,228
+5% +$29.1K 0.01% 768
2018
Q1 		$714K Buy
+24,626
New +$720K 0.02% 656

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Assured Investment Management's AVEO Position: Q2 2019 in Review

Assured Investment Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q2 2019, closing a stake of 28,081 shares — an estimated $230K sold.

Assured Investment Management first reported a position in AVEO in Q1 2018 and held it in 4 quarters. The position peaked at $714K in Q1 2018. 73 funds tracked by Wall St. Rank hold AVEO as of Q2 2019.

  • Assured Investment Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • Assured Investment Management sold 28,081 AVEO Pharmaceuticals, Inc. shares in Q2 2019, an estimated $230K.
  • Assured Investment Management first reported a position in AVEO Pharmaceuticals, Inc. in Q1 2018 and held it in 4 quarters.
  • Assured Investment Management's AVEO Pharmaceuticals, Inc. position peaked at $714K in Q1 2018.
  • 73 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.